AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $1.59 billion. The enterprise value is $1.22 billion.
Important Dates
The last earnings date was Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 305.26 million shares outstanding. The number of shares has increased by 1.52% in one year.
| Current Share Class | 305.26M |
| Shares Outstanding | 305.26M |
| Shares Change (YoY) | +1.52% |
| Shares Change (QoQ) | +1.12% |
| Owned by Insiders (%) | 22.85% |
| Owned by Institutions (%) | 28.68% |
| Float | 205.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.04 |
| Forward PS | 49.11 |
| PB Ratio | 1.68 |
| P/TBV Ratio | 1.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.05, with a Debt / Equity ratio of 0.14.
| Current Ratio | 14.05 |
| Quick Ratio | 11.45 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -14.68% and return on invested capital (ROIC) is -37.06%.
| Return on Equity (ROE) | -14.68% |
| Return on Assets (ROA) | -9.99% |
| Return on Invested Capital (ROIC) | -37.06% |
| Return on Capital Employed (ROCE) | -16.82% |
| Weighted Average Cost of Capital (WACC) | 9.13% |
| Revenue Per Employee | $140,940 |
| Profits Per Employee | -$256,149 |
| Employee Count | 562 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -30.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +161.31% in the last 52 weeks. The beta is 1.03, so ABCL's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +161.31% |
| 50-Day Moving Average | 3.99 |
| 200-Day Moving Average | 4.15 |
| Relative Strength Index (RSI) | 63.79 |
| Average Volume (20 Days) | 10,000,903 |
Short Selling Information
The latest short interest is 44.46 million, so 14.56% of the outstanding shares have been sold short.
| Short Interest | 44.46M |
| Short Previous Month | 47.70M |
| Short % of Shares Out | 14.56% |
| Short % of Float | 21.66% |
| Short Ratio (days to cover) | 8.75 |
Income Statement
In the last 12 months, ABCL had revenue of $79.21 million and -$143.96 million in losses. Loss per share was -$0.48.
| Revenue | 79.21M |
| Gross Profit | -107.62M |
| Operating Income | -211.96M |
| Pretax Income | -174.15M |
| Net Income | -143.96M |
| EBITDA | -188.28M |
| EBIT | -211.96M |
| Loss Per Share | -$0.48 |
Full Income StatementBalance Sheet
The company has $504.73 million in cash and $134.31 million in debt, with a net cash position of $370.42 million or $1.21 per share.
| Cash & Cash Equivalents | 504.73M |
| Total Debt | 134.31M |
| Net Cash | 370.42M |
| Net Cash Per Share | $1.21 |
| Equity (Book Value) | 938.08M |
| Book Value Per Share | 3.09 |
| Working Capital | 617.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$153.26 million and capital expenditures -$35.97 million, giving a free cash flow of -$189.23 million.
| Operating Cash Flow | -153.26M |
| Capital Expenditures | -35.97M |
| Depreciation & Amortization | 23.68M |
| Net Borrowing | 30.95M |
| Free Cash Flow | -189.23M |
| FCF Per Share | -$0.62 |
Full Cash Flow StatementMargins
Gross margin is -135.87%, with operating and profit margins of -267.60% and -181.74%.
| Gross Margin | -135.87% |
| Operating Margin | -267.60% |
| Pretax Margin | -219.86% |
| Profit Margin | -181.74% |
| EBITDA Margin | -237.71% |
| EBIT Margin | -267.60% |
| FCF Margin | n/a |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.52% |
| Shareholder Yield | -1.52% |
| Earnings Yield | -9.07% |
| FCF Yield | -11.92% |
Analyst Forecast
The average price target for ABCL is $10.14, which is 95.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.14 |
| Price Target Difference | 95.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 30.44% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
